Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) is pleased to offer its ordinary shareholders residing in New Zealand and Australia the option to participate in a Dividend Reinvestment Plan (DRP).
The DRP will allow eligible shareholders to elect to reinvest all or part of their cash dividends in additional Fisher & Paykel Healthcare ordinary shares.
The following documents will be despatched to eligible shareholders today in relation to the implementation of the DRP:
The first dividend that the DRP will apply to is the final dividend for the financial year ended 31 March 2009 which is payable on 6 July 2009. Participation Notices must be received by the Company’s Share Registrar by 5.00pm New Zealand time on 19 June 2009 to be effective for this final dividend.
Contact: Tony Barclay, Company Secretary on +64 9 574 0119
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Ends
Contact
|